# Darden Restaurants Inc: financial statements, quarterly

DRI · NYSE · CIK 940944 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends May 30

Pages: [Overview](/companies/dri.md) · [Financials](/companies/dri/financials.md) · [Filings](/companies/dri/filings.md) · [Insiders](/companies/dri/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dri/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-11-26) | Q3 FY2024 (2024-02-25) | Q4 FY2024 (2024-05-26) | Q1 FY2025 (2024-08-25) | Q2 FY2025 (2024-11-24) | Q3 FY2025 (2025-02-23) | Q4 FY2025 (2025-05-25) | Q1 FY2026 (2025-08-24) | Q2 FY2026 (2025-11-23) | Q3 FY2026 (2026-02-22) | Q4 FY2026 (2026-05-31) | Q1 FY2027 (2026-08-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,727](/filings/0000940944-25-000003.md) | [2,975](/filings/0000940944-25-000018.md) | [2,957 d](/filings/0000940944-26-000025.md) | [2,757](/filings/0000940944-25-000054.md) | [2,890](/filings/0000940944-25-000071.md) | [3,158](/filings/0000940944-26-000009.md) | [3,272 d](/filings/0000940944-26-000025.md) | [3,045](/filings/0000940944-26-000042.md) | [3,102](/filings/0000940944-25-000071.md) | [3,345](/filings/0000940944-26-000009.md) | [3,719 d](/filings/0000940944-26-000025.md) | [3,200](/filings/0000940944-26-000042.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [513](/filings/0000940944-25-000003.md) | [614](/filings/0000940944-25-000018.md) | [644 d](/filings/0000940944-26-000025.md) | [523](/filings/0000940944-25-000054.md) | [569](/filings/0000940944-25-000071.md) | [673](/filings/0000940944-26-000009.md) | [708 d](/filings/0000940944-26-000025.md) | [574](/filings/0000940944-26-000042.md) | [581](/filings/0000940944-25-000071.md) | [704](/filings/0000940944-26-000009.md) | [823 d](/filings/0000940944-26-000025.md) | [603](/filings/0000940944-26-000042.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [279](/filings/0000940944-25-000003.md) | [387](/filings/0000940944-25-000018.md) | [395 d](/filings/0000940944-26-000025.md) | [269](/filings/0000940944-25-000054.md) | [292](/filings/0000940944-25-000071.md) | [418](/filings/0000940944-26-000009.md) | [383 d](/filings/0000940944-26-000025.md) | [339](/filings/0000940944-26-000042.md) | [320](/filings/0000940944-25-000071.md) | [406](/filings/0000940944-26-000009.md) | [517 d](/filings/0000940944-26-000025.md) | [319](/filings/0000940944-26-000042.md) |
| Income tax | $m | [29.1](/filings/0000940944-25-000003.md) | [37.5](/filings/0000940944-25-000018.md) | [50.0 d](/filings/0000940944-26-000025.md) | [24.5](/filings/0000940944-25-000054.md) | [30.2](/filings/0000940944-25-000071.md) | [49.0](/filings/0000940944-26-000009.md) | [32.5 d](/filings/0000940944-26-000025.md) | [35.9](/filings/0000940944-26-000042.md) | [35.0](/filings/0000940944-25-000071.md) | [46.2](/filings/0000940944-26-000009.md) | [57.8 d](/filings/0000940944-26-000025.md) | [34.7](/filings/0000940944-26-000042.md) |
| Net income | $m | [212](/filings/0000940944-25-000003.md) | [313](/filings/0000940944-25-000018.md) | [308 d](/filings/0000940944-26-000025.md) | [207](/filings/0000940944-25-000054.md) | [215](/filings/0000940944-25-000071.md) | [323](/filings/0000940944-26-000009.md) | [304 d](/filings/0000940944-26-000025.md) | [258](/filings/0000940944-26-000042.md) | [237](/filings/0000940944-25-000071.md) | [307](/filings/0000940944-26-000009.md) | [405 d](/filings/0000940944-26-000025.md) | [233](/filings/0000940944-26-000042.md) |
| Diluted EPS | $ per share | [1.76](/filings/0000940944-25-000003.md) | [2.60](/filings/0000940944-25-000018.md) | not reported | [1.74](/filings/0000940944-25-000054.md) | [1.82](/filings/0000940944-25-000071.md) | [2.74](/filings/0000940944-26-000009.md) | not reported | [2.19](/filings/0000940944-26-000042.md) | [2.03](/filings/0000940944-25-000071.md) | [2.65](/filings/0000940944-26-000009.md) | not reported | [2.04](/filings/0000940944-26-000042.md) |
| Basic EPS | $ per share | [1.77](/filings/0000940944-25-000003.md) | [2.62](/filings/0000940944-25-000018.md) | not reported | [1.75](/filings/0000940944-25-000054.md) | [1.83](/filings/0000940944-25-000071.md) | [2.76](/filings/0000940944-26-000009.md) | not reported | [2.21](/filings/0000940944-26-000042.md) | [2.05](/filings/0000940944-25-000071.md) | [2.67](/filings/0000940944-26-000009.md) | not reported | [2.05](/filings/0000940944-26-000042.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-11-26) | Q3 FY2024 (2024-02-25) | FY2024 (2024-05-26) | Q1 FY2025 (2024-08-25) | Q2 FY2025 (2024-11-24) | Q3 FY2025 (2025-02-23) | FY2025 (2025-05-25) | Q1 FY2026 (2025-08-24) | Q2 FY2026 (2025-11-23) | Q3 FY2026 (2026-02-22) | FY2026 (2026-05-31) | Q1 FY2027 (2026-08-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0000940944-25-000003.md) | [0.2](/filings/0000940944-25-000018.md) | [0.2](/filings/0000940944-26-000025.md) | [0.2](/filings/0000940944-25-000054.md) | [0.2](/filings/0000940944-25-000071.md) | [0.2](/filings/0000940944-26-000009.md) | [0.2](/filings/0000940944-26-000025.md) | [0.2](/filings/0000940944-26-000042.md) | [0.2](/filings/0000940944-25-000071.md) | [0.2](/filings/0000940944-26-000009.md) | [0.2](/filings/0000940944-26-000042.md) | [0.2](/filings/0000940944-26-000042.md) |
| Current assets | $bn | [0.9](/filings/0000940944-24-000005.md) | [0.9](/filings/0000940944-24-000017.md) | [0.8](/filings/0000940944-25-000038.md) | [0.8](/filings/0000940944-24-000055.md) | [0.9](/filings/0000940944-25-000003.md) | [0.9](/filings/0000940944-25-000018.md) | [0.9](/filings/0000940944-26-000025.md) | [0.9](/filings/0000940944-25-000054.md) | [1.0](/filings/0000940944-25-000071.md) | [1.0](/filings/0000940944-26-000009.md) | [0.9](/filings/0000940944-26-000042.md) | [1.0](/filings/0000940944-26-000042.md) |
| Total assets | $bn | [11.3](/filings/0000940944-24-000005.md) | [11.4](/filings/0000940944-24-000017.md) | [11.3](/filings/0000940944-25-000038.md) | [12.8](/filings/0000940944-25-000054.md) | [12.9](/filings/0000940944-25-000071.md) | [12.6](/filings/0000940944-25-000018.md) | [12.6](/filings/0000940944-26-000025.md) | [12.8](/filings/0000940944-25-000054.md) | [12.9](/filings/0000940944-25-000071.md) | [12.9](/filings/0000940944-26-000009.md) | [12.9](/filings/0000940944-26-000042.md) | [13.2](/filings/0000940944-26-000042.md) |
| Current liabilities | $bn | [2.4](/filings/0000940944-24-000005.md) | [2.3](/filings/0000940944-24-000017.md) | [2.2](/filings/0000940944-25-000038.md) | [2.3](/filings/0000940944-24-000055.md) | [2.4](/filings/0000940944-25-000003.md) | [2.3](/filings/0000940944-25-000018.md) | [2.2](/filings/0000940944-26-000025.md) | [2.3](/filings/0000940944-25-000054.md) | [2.7](/filings/0000940944-25-000071.md) | [2.6](/filings/0000940944-26-000009.md) | [3.0](/filings/0000940944-26-000042.md) | [3.2](/filings/0000940944-26-000042.md) |
| Total liabilities | $bn | [9.3](/filings/0000940944-24-000005.md) | [9.2](/filings/0000940944-24-000017.md) | [9.1](/filings/0000940944-25-000038.md) | [9.2](/filings/0000940944-24-000055.md) | [10.4](/filings/0000940944-25-000003.md) | [10.4](/filings/0000940944-25-000018.md) | [10.3](/filings/0000940944-26-000025.md) | [10.5](/filings/0000940944-25-000054.md) | [10.9](/filings/0000940944-25-000071.md) | [10.8](/filings/0000940944-26-000009.md) | [10.7](/filings/0000940944-26-000042.md) | [11.2](/filings/0000940944-26-000042.md) |
| Long-term debt | $bn | [1.4](/filings/0000940944-24-000005.md) | [1.4](/filings/0000940944-24-000017.md) | [1.4](/filings/0000940944-25-000038.md) | [1.4](/filings/0000940944-24-000055.md) | [2.1](/filings/0000940944-25-000003.md) | [2.1](/filings/0000940944-25-000018.md) | [2.1](/filings/0000940944-26-000025.md) | [2.1](/filings/0000940944-25-000054.md) | [2.1](/filings/0000940944-25-000071.md) | [2.1](/filings/0000940944-26-000009.md) | [1.6](/filings/0000940944-26-000042.md) | [1.6](/filings/0000940944-26-000042.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0000940944-26-000025.md) | not reported | not reported | not reported | [0.7](/filings/0000940944-26-000025.md) | not reported |
| Short-term borrowings | $bn | [0.4](/filings/0000940944-24-000005.md) | [0.2](/filings/0000940944-24-000017.md) | [0.1](/filings/0000940944-25-000038.md) | [0.3](/filings/0000940944-24-000055.md) | [0.3](/filings/0000940944-25-000003.md) | [0.1](/filings/0000940944-25-000018.md) | [0.0](/filings/0000940944-26-000009.md) | [0.1](/filings/0000940944-25-000054.md) | [0.4](/filings/0000940944-25-000071.md) | [0.3](/filings/0000940944-26-000009.md) | [0.7](/filings/0000940944-26-000042.md) | [1.0](/filings/0000940944-26-000042.md) |
| Shareholders' equity | $bn | [2.0](/filings/0000940944-25-000018.md) | [2.2](/filings/0000940944-25-000018.md) | [2.2](/filings/0000940944-26-000025.md) | [2.1](/filings/0000940944-25-000071.md) | [2.1](/filings/0000940944-26-000009.md) | [2.2](/filings/0000940944-26-000009.md) | [2.3](/filings/0000940944-26-000042.md) | [2.2](/filings/0000940944-26-000042.md) | [2.1](/filings/0000940944-26-000009.md) | [2.1](/filings/0000940944-26-000009.md) | [2.2](/filings/0000940944-26-000042.md) | [2.1](/filings/0000940944-26-000042.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-11-26) | Q3 FY2024 (2024-02-25) | Q4 FY2024 (2024-05-26) | Q1 FY2025 (2024-08-25) | Q2 FY2025 (2024-11-24) | Q3 FY2025 (2025-02-23) | Q4 FY2025 (2025-05-25) | Q1 FY2026 (2025-08-24) | Q2 FY2026 (2025-11-23) | Q3 FY2026 (2026-02-22) | Q4 FY2026 (2026-05-31) | Q1 FY2027 (2026-08-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [341 d](/filings/0000940944-25-000003.md) | [586 d](/filings/0000940944-25-000018.md) | [426 d](/filings/0000940944-26-000025.md) | [273](/filings/0000940944-25-000054.md) | [389 d](/filings/0000940944-25-000071.md) | [588 d](/filings/0000940944-26-000009.md) | [457 d](/filings/0000940944-26-000025.md) | [343](/filings/0000940944-26-000042.md) | [321 d](/filings/0000940944-25-000071.md) | [618 d](/filings/0000940944-26-000009.md) | [572 d](/filings/0000940944-26-000025.md) | [279](/filings/0000940944-26-000042.md) |
| Capital expenditure | $m | [162 d](/filings/0000940944-25-000003.md) | [148 d](/filings/0000940944-25-000018.md) | [140 d](/filings/0000940944-26-000025.md) | [145](/filings/0000940944-25-000054.md) | [169 d](/filings/0000940944-25-000071.md) | [158 d](/filings/0000940944-26-000009.md) | [172 d](/filings/0000940944-26-000025.md) | [174](/filings/0000940944-26-000042.md) | [201 d](/filings/0000940944-25-000071.md) | [166 d](/filings/0000940944-26-000009.md) | [193 d](/filings/0000940944-26-000025.md) | [175](/filings/0000940944-26-000042.md) |
| Dividends paid | $m | [157 d](/filings/0000940944-25-000003.md) | [156 d](/filings/0000940944-25-000018.md) | [156 d](/filings/0000940944-26-000025.md) | [166](/filings/0000940944-25-000054.md) | [165 d](/filings/0000940944-25-000071.md) | [164 d](/filings/0000940944-26-000009.md) | [164 d](/filings/0000940944-26-000025.md) | [175](/filings/0000940944-26-000042.md) | [174 d](/filings/0000940944-25-000071.md) | [173 d](/filings/0000940944-26-000009.md) | [172 d](/filings/0000940944-26-000025.md) | [184](/filings/0000940944-26-000042.md) |
| Share repurchases | $m | [181 d](/filings/0000940944-25-000003.md) | [32.7 d](/filings/0000940944-25-000018.md) | [97.3 d](/filings/0000940944-26-000025.md) | [172](/filings/0000940944-25-000054.md) | [142 d](/filings/0000940944-25-000071.md) | [53.0 d](/filings/0000940944-26-000009.md) | [51.0 d](/filings/0000940944-26-000025.md) | [183](/filings/0000940944-26-000042.md) | [224 d](/filings/0000940944-25-000071.md) | [127 d](/filings/0000940944-26-000009.md) | [137 d](/filings/0000940944-26-000025.md) | [221](/filings/0000940944-26-000042.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-11-27) | Q3 FY2023 (2023-02-26) | Q1 FY2024 (2023-08-27) | Q2 FY2024 (2023-11-26) | Q3 FY2024 (2024-02-25) | Q1 FY2025 (2024-08-25) | Q2 FY2025 (2024-11-24) | Q3 FY2025 (2025-02-23) | Q1 FY2026 (2025-08-24) | Q2 FY2026 (2025-11-23) | Q3 FY2026 (2026-02-22) | Q1 FY2027 (2026-08-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [123](/filings/0000940944-24-000005.md) | [123](/filings/0000940944-24-000017.md) | [122](/filings/0000940944-24-000055.md) | [121](/filings/0000940944-25-000003.md) | [120](/filings/0000940944-25-000018.md) | [119](/filings/0000940944-25-000054.md) | [118](/filings/0000940944-25-000071.md) | [118](/filings/0000940944-26-000009.md) | [118](/filings/0000940944-26-000042.md) | [117](/filings/0000940944-25-000071.md) | [116](/filings/0000940944-26-000009.md) | [114](/filings/0000940944-26-000042.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 113,143,224 at 2026-09-21, from the cover of the [10-Q filed 2026-10-02](/filings/0000940944-26-000042.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.